Hubei Jumpcan Pharmaceutical Co., Ltd.

¥29.28As of Sun 8 Nov 2026, 12:00 UTC
SSE:600566Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR 2.87%
Div yield 5.94%
ROE 12.87%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.07
PE TTM 14.87
TSR TTM 25.09%
Mkt cap ¥26.99B
ROIC 43.57%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥34
16.77%
(92.46%)
Hold 9|8|5|11|3
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.55
0.57
0.56
0.55
7.21%
12.16%
5.23%
(0.32%)
Revenue¥B
1.420
1.415
1.419
1.498
2.02%
4.46%
5.46%
7.68%
Peers (US$4.046B)
Cap (US$)
PE
4.020B
19.40x
3.934B
28.04x
3.974B
30.04x
Capital
TTM
5Y
10Y
Leveragex
1.731
(0.022)
(0.012)
EBIT/Intx
0.435
0.115
0.125
Own earn%
4.02
55.63
56.43
Sh yield%
39.71
60.30
56.53
Owners
Insiders/Inst%
7.22
89.21
Short interest%
5.91
SBC / revenue%
1.72
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
0–3
$1 testx
—
Incr. ROIC%
2